Kenji Nakamaru
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer-related Molecular Pathways, HER2/EGFR in Cancer Research, Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes
Most-Cited Works
- → A cardiac myosin light chain kinase regulates sarcomere assembly in the vertebrate heart(2007)159 cited
- → NTRK3 kinase fusions in Spitz tumours(2016)151 cited
- → Identification of genes related to heart failure using global gene expression profiling of human failing myocardium(2010)110 cited
- → U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid Tumors(2020)105 cited
- → Predictive Gene Signatures Determine Tumor Sensitivity to MDM2 Inhibition(2018)58 cited
- → Impact of Adenosine Receptor Signaling and Metabolism on Pathophysiology in Patients with Chronic Heart Failure(2007)57 cited
- → Development of Novel Simian Immunodeficiency Virus Vectors Carrying a Dual Gene Expression System(2000)52 cited
- → Clinical Translation and Validation of a Predictive Biomarker for Patritumab, an Anti-human Epidermal Growth Factor Receptor 3 (HER3) Monoclonal Antibody, in Patients With Advanced Non-small Cell Lung Cancer(2015)49 cited
- → Safety and pharmacokinetics of DS-6051b in Japanese patients with non-small cell lung cancer harboring ROS1 fusions: a phase I study(2018)39 cited
- → Patritumab deruxtecan (HER3-DXd), a novel HER3 directed antibody drug conjugate, exhibits in vitro activity against breast cancer cells expressing HER3 mutations with and without HER2 overexpression(2022)22 cited